New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

NBJ

Endomatrix Positions Products on Preventive Health Platform

Product development company targets heart disease prevention by enhancing endothelial function

Basing a supplement business on clinical science can be a costly and highrisk positioning strategy but one that could also pay off handsomely in the long term. Endomatrix Inc. is a venture capital backed company positioned biotech-style upon a platform of vascular endothelial function rather than a particular product.

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email info@nutritionbusiness.com for more information about subscribing.